Glimitab-MV 1 Tablet
Glimitab-MV 1 Tablet
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.2mg)
Glynamic MV 1 Tablet
Fusion Healthcare Pvt Ltd
Voglibose 0.2mg
Pack Size
strip of 10 tablets
Price
Save ₹44
that's 32% off!
About This Medicine
Product description & overview
Glimitab-MV 1 Tablet: A Triple-Action Approach to Blood Sugar Control
Glimitab-MV 1 Tablet is a combination medication specifically formulated to manage type 2 diabetes. It combines three key ingredients:
* Glimepiride (1mg): Helps regulate blood sugar levels by stimulating the release of insulin from the pancreas.
* Metformin (500mg): Lowers blood glucose levels by reducing glucose production in the liver and increasing glucose sensitivity.
* Voglibose (0.2mg): Acts on the digestive system to decrease postprandial glucose spikes, further aiding in controlling blood sugar.
This synergistic combination provides comprehensive action for effective blood sugar management. The single tablet dosage offers convenience and flexibility.
Always consult with a healthcare professional before starting or changing any medication regimen.
Active composition
Metformin 500 mg
+2 more active ingredients
About Metformin
Metformin is an oral antihyperglycemic agent used to manage type 2 diabetes mellitus. It works by decreasing glucose production in the liver and improving insulin sensitivity. Metformin is effective in controlling blood sugar levels and preventing diabetes-related complications. In summary, Metformin is vital for managing type 2 diabetes.
How It Works
Metformin reduces hepatic glucose production and enhances peripheral insulin sensitivity, lowering blood glucose levels.
All Active Ingredients
Glimepiride
Glimepiride stimulates insulin secretion from pancreatic beta cells and enhances insulin sensitivity in peripheral tissues, facilitating glucose uptake and lowering blood sugar levels.
Voglibose
Voglibose inhibits intestinal alpha-glucosidases, delaying carbohydrate digestion and absorption, thus lowering postprandial glucose levels.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
It is unsafe to consume alcohol with Glimitab-MV 1 Tablet.
High Risk
Pregnancy
Glimitab-MV 1 Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Medical Advice
Driving
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Exercise Caution
Liver
Glimitab-MV 1 Tablet should be used with caution in patients with liver disease. Dose adjustment of Glimitab-MV 1 Tablet may be needed. Please consult your doctor. Glimitab-MV 1 Tablet is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Regular Checkup
Breastfeeding
Glimitab-MV 1 Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Consult Doctor
Kidney
Glimitab-MV 1 Tablet is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glimitab-MV 1 Tablet is, however, not recommended in patients with severe kidney disease.
Regular Checkup
Customer Reviews
0 reviews for Glimitab-MV 1 Tablet
Products matching your search
HQ-Star 200 Tablet
HQ-Star 200 Tablet
Enzicord 300 Capsule
Enzicord 300 Capsule
Lefumide 10 Tablet
Lefumide 10 Tablet
Lefra 20 Tablet
Lefra 20 Tablet
Flutitroy-FTA Nasal Spray
Flutitroy-FTA Nasal Spray
Carwin 500 Tablet
Carwin 500 Tablet
Oxcq 400 Tablet
Oxcq 400 Tablet
Fertyl Tablet